Andrew Jakymiw, Ph.D.
The study of RNA silencing-based therapies for cancer, in particular, the development of peptide carrier-mediated targeted delivery strategies of therapeutic small RNA molecules for the treatment of oral cancer
Research Interest
I am an Associate Professor in the Department of Biomedical and Community Health Sciences at the Medical University of South Carolina (MUSC), and my laboratory research is focused on the development of cell-penetrating peptide (CPP)-mediated targeted delivery strategies for therapeutic nucleic acid-based drugs in the treatment of varied diseases, including cancer and age-related macular degeneration (AMD). Moreover, my laboratory is also involved in the study of cell entry mechanisms that peptide carriers employ to deliver various nucleic acid-based cargos into cells, which could prove instrumental in informing new peptide designs toward the advancement of more efficacious peptide carriers for human therapies.